| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/26/2014 | WO2014096384A1 Use of antisecretory factor (af) in glioblastoma treatment |
| 06/26/2014 | WO2014096368A1 Pyrrolobenzodiazepines and conjugates thereof |
| 06/26/2014 | WO2014096365A1 Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases |
| 06/26/2014 | WO2014095833A1 Combination comprising radium-223 for the treatment of cancer |
| 06/26/2014 | WO2014094528A1 Compounds and methods for the treatment of cd20 positive diseases |
| 06/26/2014 | WO2014094527A1 Compounds and methods for the treatment of erb b2/neu positive diseases |
| 06/26/2014 | WO2014094355A1 Compounds and methods for the treatment of egfr positive diseases |
| 06/26/2014 | WO2014094353A1 Maytansinoid derivatives |
| 06/26/2014 | WO2014094182A1 Non-replicating virus-derived particles and uses thereof |
| 06/26/2014 | WO2014094178A1 Radiosensitizer compounds for use in combination with radiation |
| 06/26/2014 | WO2014094176A1 Uses and methods for the treatment of liver diseases or conditions |
| 06/26/2014 | WO2014094122A1 Treatment of cd47+ disease cells with sirp alpha-fc fusions |
| 06/26/2014 | WO2014066507A9 Allogeneic autophagosome-enriched composition for the treatment of disease |
| 06/26/2014 | WO2014062878A3 Treatment of prostate cancer with tor kinase inhibitors |
| 06/26/2014 | WO2013082563A8 Protein inhibitors to complement and vegf pathways and methods of use thereof |
| 06/26/2014 | WO2012162628A3 Lipopeptide inhibitors of ras oncoproteins |
| 06/26/2014 | WO2009035791A9 Lox and l0xl2 inhibitors and uses thereof |
| 06/26/2014 | US20140179760 In vivo production of small interfering rnas that mediate gene silencing |
| 06/26/2014 | US20140179617 Cytotoxic Factors For Modulating Cell Death |
| 06/26/2014 | US20140179596 Albumin fusion proteins |
| 06/26/2014 | US20140179563 Method and Nucleic Acids for the Analysis of Colorectal Cell Proliferative Disorders |
| 06/26/2014 | US20140178986 Soluble inhibitors of vascular endothelial growth factor and use thereof |
| 06/26/2014 | US20140178969 Viral purification methods |
| 06/26/2014 | US20140178509 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent |
| 06/26/2014 | US20140178403 Method of inhibiting binding or activity of mif by administering a mif antagonist |
| 06/26/2014 | US20140178369 Treatment with anti-vegf antibodies |
| 06/26/2014 | DE102012024749A1 Tumorprävention und -therapie durch Induktion einer Tumorseneszenz Tumor prevention and therapy by inducing Tumorseneszenz |
| 06/25/2014 | EP2746404A1 Antitumor agent and therapeutic effect prediction method for patients with kras-mutated colorectal cancer |
| 06/25/2014 | EP2746388A2 Recombinant adenovirus comprising trans-splicing ribozyme and cancer-treating gene, and use thereof |
| 06/25/2014 | EP2746286A1 Aminated derivative of homoharringtonine, preparation method therefor, and application thereof |
| 06/25/2014 | EP2746285A1 Process for the preparation of aurora kinase inhibitors |
| 06/25/2014 | EP2746283A1 Pyrimidopyrimidone derivatives, pharmaceutical compositions and uses thereof |
| 06/25/2014 | EP2746281A2 7-azaindole derivatives |
| 06/25/2014 | EP2746268A1 Method for chemical synthesis of antrocin and use thereof for suppressing non-small cell lung cancer |
| 06/25/2014 | EP2746251A2 Positively charged water-soluble prodrugs of acetaminophen and related compunds with very fast skin penetration rate |
| 06/25/2014 | EP2745850A1 Nano-particles for internal radiation therapy of involved area, and therapy system |
| 06/25/2014 | EP2745846A1 Drug for preventing exacerbation of malignant tumor, comprising combination of natriuretic peptide receptor gc-a agonist and gc-b agonist |
| 06/25/2014 | EP2745842A2 Anti-cancer composition comprising wnt decoy receptors |
| 06/25/2014 | EP2744918A1 Yeast-muc1 immunotherapeutic compositions and uses thereof |
| 06/25/2014 | EP2744830A1 Lsr antibodies, and uses thereof for treatment of cancer |
| 06/25/2014 | EP2744829A1 Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam) |
| 06/25/2014 | EP2744828A1 Jaml specific binding agents, antibodies, and uses related thereto |
| 06/25/2014 | EP2744827A1 Anti-tie2 antibodies uses thereof |
| 06/25/2014 | EP2744825A1 Inhibition of angiogenesis in refractory tumors |
| 06/25/2014 | EP2744824A1 Neuregulin antibodies and uses thereof |
| 06/25/2014 | EP2744808A2 Tricyclic compounds as anticancer agents |
| 06/25/2014 | EP2744786A1 Substituted 2-imidazolidinones and 2-imidazolones and their use in the treatment of cancer |
| 06/25/2014 | EP2744518A2 Use of small molecules in methods for purification of biomolecules |
| 06/25/2014 | EP2744513A1 Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors |
| 06/25/2014 | EP2744508A1 Vegf-binding protein for blockade of angiogenesis |
| 06/25/2014 | EP2744500A1 Compounds for use in cancer therapy |
| 06/25/2014 | EP2744494A1 Combination cancer therapy of hsp90 inhibitor with antimetabolite |
| 06/25/2014 | EP2744483A1 Delivery system for specifically targeting cancer cells and method of use thereof |
| 06/25/2014 | CN1646141B 用于治疗病毒感染和异常细胞增殖的修饰核苷类化合物 For the treatment of viral infections and abnormal cell proliferation modified nucleoside compounds |
| 06/25/2014 | CN103890177A Hpv嵌合颗粒 Hpv chimeric particles |
| 06/25/2014 | CN103890010A 抗-人-her3抗体及其用途 Anti - human -her3 antibodies and their use |
| 06/25/2014 | CN103890008A 在顽固性肿瘤中抑制血管发生 Inhibition of angiogenesis in tumors refractory |
| 06/25/2014 | CN103890007A 神经调节蛋白抗体及其用途 Neuregulin antibodies and their use |
| 06/25/2014 | CN103890006A 抗mcsp抗体 Anti-mcsp antibody |
| 06/25/2014 | CN103889988A Nedd8-活化酶的抑制剂 Nedd8- activating enzyme inhibitor |
| 06/25/2014 | CN103889987A 作为btk-抑制剂的4-咪唑并哒嗪-1-基-苯甲酰胺类和4-咪唑并三嗪-1-基-苯甲酰胺类 As btk- inhibitor 4-imidazolyl-1-yl and pyridazin - benzamide and 4-triazin-1-yl-imidazo - benzamides |
| 06/25/2014 | CN103889986A 新杂环衍生物及其应用 New heterocyclic derivatives and its application |
| 06/25/2014 | CN103889981A 作为抗癌剂的三环化合物 Tricyclic compounds as anticancer agents |
| 06/25/2014 | CN103889947A 自磁性金属萨伦络合化合物 Since magnetic metal Salen complex compounds |
| 06/25/2014 | CN103889457A 使用特异性的基于壳聚糖的纳米复合物用于有效并安全递送siRNA的组合物和方法 The compositions and methods using specific chitosan-based nanocomposites for efficient delivery of siRNA to secure |
| 06/25/2014 | CN103889452A 对t细胞活化性抗原和肿瘤抗原特异性的双特异性抗体及使用方法 Of t cell activation antigens and tumor antigen-specific bispecific antibodies and methods of use |
| 06/25/2014 | CN103889451A 与C-Met相关的生物物质 Associated with the C-Met biomass |
| 06/25/2014 | CN103889440A 用于癌症治疗和预防的涉及p62的方法和组合物 For cancer treatment and prevention methods and compositions involved in the p62 |
| 06/25/2014 | CN103889418A 使用PI3Kβ抑制剂和包括MEK和RAF抑制剂的MAPK通道抑制剂治疗癌症的组合物和方法 Use PI3Kβ including MAPK inhibitors and inhibitors of RAF and MEK channel inhibitors for cancer treatment compositions and methods |
| 06/25/2014 | CN103889412A 新型苯胺衍生物及其用途 The new aniline derivatives and their use |
| 06/25/2014 | CN103889409A N-羟基-4-{2-[3-(n,n-二甲基氨基甲基)苯并呋喃-2-基羰基氨基]乙氧基}苯甲酰胺的给药方案 N- hydroxy -4- {2- [3- (n, n- dimethylamino-methyl) benzofuran-2-yl-carbonyl amino] ethoxy} benzamide dosing regimen |
| 06/25/2014 | CN103882124A 用于乳腺癌的诊断、预后和治疗的基于MicroRNA的方法和组合物 Methods and compositions for the diagnosis, prognosis and treatment of breast cancer is based MicroRNA |
| 06/25/2014 | CN103882057A 携带p21ras单链抗体基因肿瘤特异性腺病毒载体的构建及其应用 P21ras carry tumor-specific single chain antibody gene adenovirus vector and its application |
| 06/25/2014 | CN103882026A 一种重组制癌肽的制备方法 A method for preparing a recombinant cancer peptide prepared |
| 06/25/2014 | CN103882020A 针对微小rna-155种子序列的反义寡核苷酸及应用 Antisense oligonucleotides and applications for small rna-155 seed sequence |
| 06/25/2014 | CN103881984A 无血清悬浮细胞生产重组腺病毒的方法及其药品制剂生产方法 Serum-free suspension cells to produce recombinant adenovirus preparation method and pharmaceutical production methods |
| 06/25/2014 | CN103881700A 一类噻吩基磷光铱配合物及其制备方法和应用 A class-thienyl phosphorescent iridium complex and its preparation method and application |
| 06/25/2014 | CN103881088A 一种响应性聚合物胶束载药体系及其制备方法 One responsive polymer micelle drug system and its preparation method |
| 06/25/2014 | CN103881084A 一种支化聚乙二醇的磷脂类衍生物及其组成的脂质膜结构体 One branched polyethylene glycol phospholipid derivatives of the lipid membrane structure and composition of body |
| 06/25/2014 | CN103880965A 被导靶的干扰素显示强的细胞凋亡和抗肿瘤活性 Is turned on to show a strong interferon target cell apoptosis and anti-tumor activity |
| 06/25/2014 | CN103880964A 一种重组融合蛋白vip-tat及其应用 A recombinant fusion protein and its application vip-tat |
| 06/25/2014 | CN103880963A 半乳糖凝集素-3C（Galectin-3C) 抗体融合蛋白的制备方法和用途 Galectin -3C (Galectin-3C) antibody fusion protein preparation and use |
| 06/25/2014 | CN103880959A 一种抗p21ras蛋白的单链抗体及其应用 An anti-p21ras protein single-chain antibody and its application |
| 06/25/2014 | CN103880958A 抗cd20抗原的抗体l4h6及其应用 Anti-cd20 antigens l4h6 Its Applications |
| 06/25/2014 | CN103880957A 抗cd20抗原的抗体l1h1及其应用 Anti-cd20 antigens l1h1 Its Applications |
| 06/25/2014 | CN103880956A 抗muc1单克隆抗体及其轻链和重链可变区 Monoclonal antibodies and anti muc1 light chain and heavy chain variable region |
| 06/25/2014 | CN103880955A 肝细胞生长因子的特异性结合物 Hepatocyte growth factor specific binding |
| 06/25/2014 | CN103880949A 类载脂蛋白ci及其在制备治疗肾母细胞瘤的药物中的应用 Apolipoprotein class ci and drugs in the treatment of Wilms tumor preparation of application |
| 06/25/2014 | CN103880937A 一种萨氏海鞘抗肿瘤多肽及制备方法和应用 One kind of anti-tumor peptide Sabouraud sea squirts and preparation method and application |
| 06/25/2014 | CN103880929A 茜草科类型环肽用作为肿瘤转移抑制剂和其制备方法与应用 Rubiaceae type of cyclic peptide used as an inhibitor of tumor metastasis and its preparation method and application |
| 06/25/2014 | CN103880910A 一种环黄芪醇的制备方法及其用途 Preparation method of ring astragalus alcohol and its use |
| 06/25/2014 | CN103880900A 一种黄酮苷化合物及其制备方法和用途 One kind of flavonoid glycoside compounds and their preparation and use |
| 06/25/2014 | CN103880890A 新型抗肿瘤药物钌（Ⅱ）配合物及其制备方法 New anticancer drugs Ruthenium (Ⅱ) complex and its preparation method |
| 06/25/2014 | CN103880869A 一种抗癌药物[Cu<sub>2</sub>(L<sup>4</sup>)(L<sup>6</sup>)]及其原位合成方法 An anticancer drug [Cu <sub> 2 </ sub> (L <sup> 4 </ sup>) (L <sup> 6 </ sup>)] and in-situ synthesis method |
| 06/25/2014 | CN103880861A 一种作用于FGF受体的4,6-二甲基-噁唑并[5,4-d]嘧啶-5,7（4H,6H）-二酮衍生物 One kind of effect on FGF receptors 4,6-dimethyl - oxazolo [5,4-d] pyrimidine -5,7 (4H, 6H) - dione derivatives |
| 06/25/2014 | CN103880842A 具HDAC抑制活性的β-咔啉类衍生物及制备方法和用途 With HDAC inhibitory activity of β- carboline derivatives and the preparation and use |
| 06/25/2014 | CN103880841A 含有β-咔啉-3-酰亚肼基的HDAC抑制剂及其制备方法和用途 HDAC inhibitors and their preparation and use containing β- carboline-3-acid hydrazonopropionate of |
| 06/25/2014 | CN103880839A 13a-(S)去氧娃儿藤宁衍生物、其药物组合物与用途 13a- (S) tylophora Ning-deoxy derivatives, pharmaceutical compositions and uses |
| 06/25/2014 | CN103880833A 达沙替尼一水合物的新晶形及其制备方法和药物组合物 Dasatinib monohydrate crystal form and preparation of new methods and pharmaceutical compositions |
| 06/25/2014 | CN103880831A N-(2-氟苯基)-2,6-二氟苯磺酰胺的衍生物及其应用 N- (2- fluorophenyl) -2,6-difluorobenzene-sulfonamide derivatives and their Applications |